| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8454497 | Lung Cancer | 2016 | 8 Pages |
Abstract
approximately 18% developed symptomatic BM after stage III diagnosis, not dependent on type of chemotherapy regimen used within a CRT treatment.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Lizza E.L. Hendriks, -->Anita J.W.M. Brouns, Mohammad Amini, Wilma Uyterlinde, Robin Wijsman, Jan Bussink, Bonne Biesma, S. Bing Oei, Jos -->A. Stigt, Gerben P. Bootsma, José S.A. Belderbos, Dirk K.M. De Ruysscher, Michel M. Van den Heuvel,